PCN34 - PEMBROLIZUMAB PLUS CHEMOTHERAPY FOR FIRST-LINE TREATMENT OF METASTATIC NON-SQUAMOUS NSCLC – A NETWORK META-ANALYSIS
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.116
https://www.valueinhealthjournal.com/article/S1098-3015(18)33416-8/fulltext
Title :
PCN34 - PEMBROLIZUMAB PLUS CHEMOTHERAPY FOR FIRST-LINE TREATMENT OF METASTATIC NON-SQUAMOUS NSCLC – A NETWORK META-ANALYSIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33416-8&doi=10.1016/j.jval.2018.09.116
First page :
Section Title :
Open access? :
No
Section Order :
581